RAPT Therapeutics's total assets for Q1 2025 were $187.57M, a decrease of -21.95% from the previous quarter. RAPT total liabilities were $10.20M for the fiscal quarter, a -79.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.